スポンサーリンク
Department of Cancer and Thoracic Surgery, Okayama University Medical School | 論文
- Recovery of protein-losing enteropathy after living-donor lobar lung transplantation in primary pulmonary hypertension
- Recovery of Cardiac Function After Living-Donor Lung Transplantation in a Patient With Primary Pulmonary Hypertension
- Epoprostenol Therapy Decreases Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Primary Pulmonary Hypertension
- Bronchogenic Cyst With High Serum Carcinoembryonic Antigen
- Effects of Inhaled Nitric Oxide in a Canine Living-Donor Lobar Lung Transplant Model
- Intermittent Pneumatic Compression Is Effective in Preventing Symptomatic Pulmonary Embolism After Thoracic Surgery
- Referrals for Lung Transplantation in Japan Unique Indications and Necessity of Living-Donor Lobar Lung Transplantation
- Effect of a Single Injection of High-Dose FK506 on Lung Transplantation in Rats
- Transintestinal Systemic Oxygenation Using Perfluorocarbon
- Transintestinal Oxygenation with Perfluorocarbon : Investigation of Perfusion Rate
- Hemodynamic Effects of Pumpless Extracorporeal Membrane Oxygenation (ECMO) Support for Chronically Pressure-Overloaded Right Heart Failure in a Canine Experimental Model
- Non-small Cell Lung Cancer Coexisting with Pulmonary Aspergilloma
- Allowable Warm Ischemic Time to Tracheal Extraction for Allotransplantation of Cryopreserved Trachea
- Living-Donor Lobar Lung Transplantation for End-Stage Primary Pulmonary Hypertension
- Inhaled Nitric Oxide Ameliorates Postoperative Acute Graft Dysfunction After Living-Donor Lobar Lung Transplantation
- One Year Follow-Up of The First Bilateral Living-Donor Lobar Lung Transplantation in Japan
- The Effects of Recombinant Tissue-Type Plasminogen Activator (rt-PA) on Canine Cadaver Lung Transplantation
- A Case of Thoracoscopic Bilateral Lung Volume Reduction Surgery in a Supine Position
- Effects of Inhaled Nitric Oxide in Canine Lung Transplantation from Non-Heart-Beating Donor
- Significance of volume-reduction surgery for far-advanced gastric cancer during treatment with novel anticancer agents